Prevention of neural tube defects

Teratology

Volumn 56, Issue 1-2, 1997, Pages 17-18

  Mulinare, Joseph ^a   Erickson, J David ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; HEALTH PROGRAM; HUMAN; NEURAL TUBE DEFECT; NEWBORN; PREGNANCY TERMINATION; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; SPINA BIFIDA; UNITED STATES;

FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; NEURAL TUBE DEFECTS; PREGNANCY;

EID: 0030779604     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199707/08)56:1/2<17::AID-TERA5>3.0.CO;2-Z     Document Type: Short Survey

References (4)

1. Cragan JD, Roberts HE, Edmonds LD, et al. (1995) Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis-United States, 1985-1994. MMWR CDC Surveill Summ 44:(No. SS-4):1-13.
2. Daly LE, Kirke PN, Malloy A, Weir DG, Scott JM (1995) Folate levels and neural tube defects. JAMA 274:1698-1702.
3. Food and Drug Administration (1996) Food standards:amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register 61:8781-8797.
4. Oakley GP, Erickson JD, Adams MJ (1995) Urgent need to increase folic acid consumption. JAMA 274:1717-1718.